NEW ORLEANS -- Patients experiencing major heart attacks had a lower risk of serious complications if they received a single ...

Zalunfiban, a prehospital platelet inhibitor given by injection at the point of first medical contact for suspected STEMI, ...

复旦大学附属中山医院葛均波院士团队在11万余ST段抬高型心肌梗死（STEMI）患者中进行的研究表明，当前EMS呼叫延迟中位时间为46分钟，老年人、女性、夜间发病 （00:00~05:59）及非持续性胸痛/胸闷患者更可能延迟。

With new phase 3 data backing the ability of its emergency use zalunfiban to fend off further heart damage, CeleCor ...

The drug, delivered by EMS as a single injection, improved infarct-related patency at cath lab arrival and 30-day clinical outcomes.

Rapid treatment with CeleCor Therapeutics' investigational heart-attack drug, zalunfiban, resulted in higher levels of blood flow to the heart and an approximately 21% reduction in a patient's risk of ...

The intracoronary fibrinolysis infusion joins a host of other failed treatments to improve microvascular obstruction after STEMI.

A study was conducted to examine the predictive performance of an AI ECG algorithm for identifying occlusive myocardial infarction.

Patients receiving oral niacinamide for nonmelanoma skin cancer chemoprophylaxis show fewer cardiac events, a retrospective ...

This news was covered by the Medical Dialogues Bureau, which was present at the TCT Conference 2025 held in San Francisco, ...